- Home
- BOBS vs ELVN Comparison
BOBS vs ELVN Comparison
Compare BOBS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$12.27
HOLD
Current Price
$45.75
Company Overview
Basic Information| Metric | BOBS | ELVN |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BOBS | ELVN |
|---|---|---|
| Price | $12.27 | $45.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | $23.73 | ★ $43.40 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.58 | N/A |
| Revenue Next Year | $7.43 | N/A |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.20 | $14.79 |
| 52 Week High | $23.11 | $48.53 |
Technical Indicators
Market Signals| Indicator | BOBS | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 66.28 |
| Support Level | $10.28 | $17.48 |
| Resistance Level | $23.11 | N/A |
| Average True Range (ATR) | 0.82 | 2.44 |
| MACD | 0.42 | 0.11 |
| Stochastic Oscillator | 67.25 | 75.84 |
Price Performance
Historical Comparison BOBS
ELVN
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.